Longboat vs. AQ Platform

Longboat is a cloud-based platform tailored to enhance the efficiency of clinical trials, featuring an integrated Guided Compliance toolset that provides ongoing assistance to users throughout the entire process. By equipping clinical trial site personnel with vital resources, Longboat allows them to focus more on patient care. Moreover, participants can conveniently access important study information and receive timely reminders for upcoming visits. The system streamlines the management of protocol amendments, ensuring they are implemented smoothly and effectively. Additionally, Longboat centralizes the secure exchange of regulated documents among sponsors, CROs, and sites, thereby significantly improving the startup process and alleviating the burden of traditionally tedious tasks for all involved in research. With a unified support platform, all primary stakeholders—including clinical operations teams, monitors, site staff, and trial participants—can access tailored content that meets their specific needs. This holistic strategy guarantees that site staff are well-equipped with the necessary tools and resources to stay engaged and compliant while maintaining a strong focus on participant welfare. In this manner, Longboat not only enhances operational efficiency but also significantly enriches the overall experience for everyone participating in the clinical trial, fostering a more collaborative and effective research environment. By prioritizing user needs, Longboat paves the way for innovative solutions in clinical research management.

The AQ Platform is a sophisticated software solution designed specifically for overseeing clinical research across various entities such as NHS trusts, clinical trial units, investigator sites, site networks, CROs, sponsors, and academic research organizations. It includes an array of modules that support trial management, electronic documentation for both trials and investigator sites, operations in pharmacies and laboratories, quality assurance, corrective and preventive actions (CAPA), along with the digital delegation of authority. This platform facilitates the seamless integration of regulated trial records and comprehensive audit trails, leading to improved efficiency in study operations. By harnessing Connected Intelligence, the software utilizes AI to pinpoint potential gaps and propose subsequent actions, with the stipulation that each recommendation must be validated by a designated user, thereby ensuring that customer data remains confidential and is not employed for AI model training. Hosted within the UK regions of Microsoft Azure, the AQ Platform is meticulously crafted to comply with ICH E6(R3) guidelines and meets the standards anticipated by the MHRA for Good Clinical Practice inspections. Furthermore, AQ Trials has received the NHS DSPT Standards Met (2026) designation and holds Cyber Essentials certification, underscoring its dedication to security and adherence to regulatory requirements. Created by physicians specializing in Phase 1 trials, the system offers the flexibility of individual module deployment, and it has been actively implemented in NHS operations since 2020, which highlights its effectiveness and reliability in practical clinical environments. The platform is continuously being enhanced based on user feedback, ensuring it adapts to the evolving demands of clinical research while maintaining high standards of performance and user satisfaction. As a result, it stands as a robust solution in the ever-changing landscape of clinical trial management.